CHANGES IN CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE
Clinical medicine

CHANGES IN CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE

Published 2025-03-12

Authors:

O.M. Bilovol
I.I. Kniazkova
V.O. Golovachova
N.V. Kuzminova
D.О. Kіrienko
O.M. Kіrienko
L.P. Abramova

Abstract:
The purpose of the study was to investigate changes in central aortic pressure and arterial stiffness in young patients with hypertension and chronic kidney disease and to identify factors influencing these changes. We examined 74 men (mean age 27.3±3.6 years) with hypertension of the 1st and 2nd degree. Depending on the presence of chronic kidney disease, 2 groups were identified: 20 patients without chronic kidney disease (group 1) and 54 patients with chronic kidney disease of stages 1-3 (group 2). The control group included 20 men (mean age 27.1±2.3 years). It was found that in young patients with hypertension, central aortic pressure and pulse wave velocity in elastic arteries are increased compared to the control group; moreover, they are more pronounced in the presence of chronic kidney disease. It was also shown that the daily non-dipper profile and left ventricular hypertrophy were significantly more common in young patients with hypertension and chronic kidney disease compared to the group without renal disease and the control group.
Keywords:
arterial hypertension in young people central aortic pressure pulse wave velocity daily blood pressure monitoring left ventricular hypertrophy
References:
  1. Cherkun MP, Katerenchuk IP. Comparative assessment of quality of life parameters in rural and urban residents with comorbid hypertension. World of Medicine and Biology. 2023; 2(84):167-171 DOI 10.26724/2079-8334-2023-2-84-167-171.
  2. Goswami B, Reang T, Sarkar S, Sengupta S, Bhattacharjee B. Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura-A comparative study. J Family Med Prim Care. 2020;9(6):2885-2890. doi: 10.4103/jfmpc.jfmpc_187_20.
  3. Kapustnick Yu, Lutsenko, R., Sуdorenko, A. Combined pharmacological therapy including several antiarrhythmic agents for treatment of different disorders of cardiac rhythm. Georgian Medical News, 2021, 315(6), Р. 85–93.
  4. Kim HL. Arterial stiffness and hypertension. Clin Hypertens. 2023;29(1):31. doi: 10.1186/s40885-023-00258-1.
  5. Kwon A, Kim GH, Kim MS. Clinical implications of central blood pressure measured by radial tonometry and automated office blood pressure measured using automatic devices in cardiovascular diseases. Front Cardiovasc Med. 2022;9:906021. doi: 10.3389/fcvm.2022.906021.
  6. Márquez DF, Rodríguez-Sánchez E, de la Morena JS, Ruilope LM, Ruiz-Hurtado G. Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts. Nefrologia (Engl Ed). 2022;42(5):519-530. doi: 10.1016/j.nefroe.2021.10.008.
  7. Park CH, Jhee JH, Chun KH, Seo J, Lee CJ, Park SH, et al. Nocturnal systolic blood pressure dipping and progression of chronic kidney disease. Hypertens Res. 2024;47(1):215-224. doi: 10.1038/s41440-023-01368-x.
  8. Quiroga B, Díez J. Estimation of glomerular filtration rate in cardiorenal patients: a step forward. Clin Kidney J. 2023;16(7):1049-1055. doi: 10.1093/ckj/sfad083.
  9. Sachan D, Sawlani KK, Kumar A, Chaudhary SC, Dandu H, Usman K, et al. Study of central aortic blood pressure in hypertensive patients & its relation with blood pressure-lowering drugs. Indian J Med Res. 2022;156(3):524-528. doi: 10.4103/ijmr.IJMR_608_20.
  10. Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9(1):80-93. doi: 10.21037/gs.2019.12.03.
  11. Suh SH, Kim SW. Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview. Diabetes Metab J. 2023;47(5):612-629. doi: 10.4093/dmj.2023.0067.
  12. Tang A, Yang E, Ebinger JE. Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More? Curr Hypertens Rep. 2024;26(1):21-30. doi: 10.1007/s11906-023-01273-1.
  13. Wu HP, Lin MJ. Central aortic pressure and long-term outcome in hypertensive patients undergoing percutaneous coronary intervention. Sci Rep. 2020;10(1):17420. doi: 10.1038/s41598-020-74619-3.
  14. Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63(1):10-21. doi: 10.1016/j.pcad.2019.11.009.
Publication:
«World of Medicine and Biology» Vol. 21 No. 91 (2025) , с. 26-31
УДК 616.12-008.331.1+616.61-036.12]-07-053.81-055.